Abbolactone
CAS No. 52-1-7
Abbolactone ( —— )
Catalog No. M14835 CAS No. 52-1-7
Spironolactone is a potent antagonist of the androgen receptor.
Purity : >98%(HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
Size | Price / USD | Stock | Quantity |
Biological Information
-
Product NameAbbolactone
-
NoteResearch use only, not for human use.
-
Brief DescriptionSpironolactone is a potent antagonist of the androgen receptor.
-
DescriptionSpironolactone is a potent antagonist of the androgen receptor. Target: Androgen Receptor Spironolactone is a potassium sparing diuretic that acts by antagonism of aldosterone in the distal renal tubules. It is used mainly in the treatment of refractory edema in patients with congestive heart failure, nephrotic syndrome, or hepatic cirrhosis. Its effects on the endocrine system are utilized in the treatments of hirsutism and acne but they can lead to adverse effects. 5% topical spironolactone cream acts as an antiandrogen in human sebaceous glands, competing with DHT receptors and producing a decrease of labelled DHT.
-
Synonyms——
-
PathwayEndocrinology/Hormones
-
TargetAndrogen Receptor (AR)
-
RecptorAndrogen Receptor
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number52-1-7
-
Formula Weight416.57
-
Molecular FormulaC24H32O4S
-
Purity>98%(HPLC)
-
SolubilityEthanol: 20 mg/mL (48.01 mM); DMSO: 83 mg/mL (199.24 mM)
-
SMILESCC(=O)SC1CC2=CC(=O)CCC2(C3C1C4CCC5(C4(CC3)C)CCC(=O)O5)C
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Ye P, et al. Horm Metab Res. 2009 Jan;41(1):35-9.
molnova catalog
related products
-
BMS-564929
BMS-564929 is a potent, selective androgen receptor modulator (SARM) that binds to AR with Ki of 2.11 nM.
-
VPC-13566
VPC-13566 is a BF3-specific small molecule, which effectively inhibited the androgen receptor transcriptional activity and displaced the BAG1L peptide from the BF3 pocket.
-
Rolapitant hydrochlo...
Rolapitant Hydrochloride is the hydrochloride salt form of rolapitant, an orally bioavailable, centrally-acting, selective, neurokinin 1 receptor (NK1-receptor) antagonist with potential antiemetic activity.